Barclays’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.65M | Buy |
538,277
+45,105
| +9% | +$195K | ﹤0.01% | 2476 |
|
|
2025
Q4 | $1.76M | Buy |
493,172
+231,892
| +89% | +$1.42M | ﹤0.01% | 3031 |
|
|
2025
Q3 | $2.33M | Sell |
261,280
-22,979
| -8% | -$233K | ﹤0.01% | 2780 |
|
|
2025
Q2 | $2.62M | Buy |
284,259
+135,584
| +91% | +$1.16M | ﹤0.01% | 2641 |
|
|
2025
Q1 | $1.28M | Sell |
148,675
-128
| -0.1% | -$1.21K | ﹤0.01% | 2954 |
|
|
2024
Q4 | $1.6M | Sell |
148,803
-6,376
| -4% | -$49K | ﹤0.01% | 3069 |
|
|
2024
Q3 | $881K | Buy |
155,179
+64,101
| +70% | +$370K | ﹤0.01% | 3439 |
|
|
2024
Q2 | $384K | Sell |
91,078
-21,174
| -19% | -$85.6K | ﹤0.01% | 3207 |
|
|
2024
Q1 | $571K | Sell |
112,252
-98,178
| -47% | -$553K | ﹤0.01% | 3506 |
|
|
2023
Q4 | $1.96M | Buy |
210,430
+49,853
| +31% | +$343K | ﹤0.01% | 2933 |
|
|
2023
Q3 | $1.05M | Sell |
160,577
-31,574
| -16% | -$251K | ﹤0.01% | 2300 |
|
|
2023
Q2 | $1.56M | Buy |
192,151
+2,538
| +1% | +$21.7K | ﹤0.01% | 2041 |
|
|
2023
Q1 | $1.62M | Buy |
189,613
+179,613
| +1,796% | +$1.79M | ﹤0.01% | 2339 |
|
|
2022
Q4 | $92.6K | Sell |
10,000
-179,290
| -95% | -$1.92M | ﹤0.01% | 4270 |
|
|
2022
Q3 | $1.95M | Buy |
189,290
+179,290
| +1,793% | +$1.89M | ﹤0.01% | 1768 |
|
|
2022
Q2 | $100K | Sell |
10,000
-109,911
| -92% | -$1.04M | ﹤0.01% | 3767 |
|
|
2022
Q1 | $1.48M | Sell |
119,911
-72,443
| -38% | -$891K | ﹤0.01% | 2109 |
|
|
2021
Q4 | $3.33M | Buy |
+192,354
| New | +$3.65M | ﹤0.01% | 2006 |
|
|
2021
Q3 | – | Sell |
-12,768
| Closed | -$292K | – | 4740 |
|
|
2021
Q2 | $292K | Sell |
12,768
-74,003
| -85% | -$1.1M | ﹤0.01% | 3365 |
|
|
2021
Q1 | $1.3M | Buy |
86,771
+13,427
| +18% | +$147K | ﹤0.01% | 2605 |
|
|
2020
Q4 | $396K | Sell |
73,344
-7,822
| -10% | -$41.2K | ﹤0.01% | 3378 |
|
|
2020
Q3 | $369K | Sell |
81,166
-26,419
| -25% | -$114K | ﹤0.01% | 3445 |
|
|
2020
Q2 | $529K | Buy |
107,585
+39,931
| +59% | +$151K | ﹤0.01% | 3300 |
|
|
2020
Q1 | $214K | Buy |
67,654
+24,715
| +58% | +$86.1K | ﹤0.01% | 4244 |
|
|
2019
Q4 | $111K | Buy |
42,939
+21,777
| +103% | +$57.2K | ﹤0.01% | 5423 |
|
|
2019
Q3 | $67K | Sell |
21,162
-6,510
| -24% | -$18.8K | ﹤0.01% | 5749 |
|
|
2019
Q2 | $93K | Sell |
27,672
-89,828
| -76% | -$279K | ﹤0.01% | 5746 |
|
|
2019
Q1 | $358K | Buy |
+117,500
| New | +$281K | ﹤0.01% | 4382 |
|
|
2018
Q3 | – | Sell |
-57,030
| Closed | -$149K | – | 7108 |
|
|
2018
Q2 | $149K | Buy |
57,030
+48,850
| +597% | +$136K | ﹤0.01% | 4974 |
|
|
2018
Q1 | $22K | Sell |
8,180
-13,927
| -63% | -$39.4K | ﹤0.01% | 6383 |
|
|
2017
Q4 | $71K | Sell |
22,107
-1,047
| -5% | -$4.12K | ﹤0.01% | 5509 |
|
|
2017
Q3 | $96K | Buy |
23,154
+21,328
| +1,168% | +$94.8K | ﹤0.01% | 4967 |
|
|
2017
Q2 | $10K | Sell |
1,826
-12,454
| -87% | -$72K | ﹤0.01% | 6049 |
|
|
2017
Q1 | $81K | Buy |
14,280
+13,731
| +2,501% | +$70.9K | ﹤0.01% | 5037 |
|
|
2016
Q4 | $2K | Buy |
549
+242
| +79% | +$862 | ﹤0.01% | 6328 |
|
|
2016
Q3 | $1K | Buy |
+307
| New | +$1.29K | ﹤0.01% | 6364 |
|
Other funds holding AVXL
VCM
SF
VPM